CVS Health Corp Q3 Earnings Report

Investing.com – CVS Health Corp (NYSE: CVS) reported a third quarter EPS of $1.09, which is $0.46 lower than the analyst estimate of $1.55. Revenue for the quarter reached $95.4B, exceeding the consensus estimate of $92.7B.

CVS Health Corp's stock closed at $55.34, reflecting a -3.10% decline over the past 3 months and a -21.22% decrease over the last 12 months.

In the last 90 days, CVS Health Corp experienced 0 positive EPS revisions and 15 negative EPS revisions. You can view CVS Health Corp's stock price reactions to earnings here.

According to InvestingPro, CVS Health Corp's Financial Health score indicates good performance.

Stay informed about CVS Health Corp's recent earnings performance and financials here.

For upcoming earnings reports, visit Investing.com's earnings calendar.